Capital Group Private Client Services’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.58M Buy
34,569
+16,164
+88% +$1.44M 0.05% 123
2026
Q1
$1.32M Buy
18,405
+14,987
+438% +$1.15M 0.02% 177
2025
Q4
$271K Hold
3,418
﹤0.01% 271
2025
Q3
$258K Hold
3,418
﹤0.01% 267
2025
Q2
$236K Hold
3,418
﹤0.01% 273
2025
Q1
$232K Buy
+3,418
New +$205K ﹤0.01% 270
2024
Q4
Sell
-3,960
Closed -$249K 274
2024
Q3
$249K Sell
3,960
-8,095
-67% -$472K ﹤0.01% 262
2024
Q2
$712K Sell
12,055
-343,143
-97% -$21.5M 0.01% 233
2024
Q1
$28.3M Buy
355,198
+31,321
+10% +$2.39M 0.29% 94
2023
Q4
$25.6M Buy
+323,877
New +$23.1M 0.26% 97

Other funds holding CVS

Capital Group Private Client Services's CVS Position: Q2 2026 in Review

Capital Group Private Client Services increased its CVS Health (CVS) stake by 88% in Q2 2026, buying an estimated $1.44M and bringing the position to 34,569 shares worth $3.58M. The position accounts for 0.05% of the portfolio, ranked #123.

Capital Group Private Client Services first reported a position in CVS in Q4 2023 and has held it in 10 quarters since. The position peaked at $28.3M in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Capital Group Private Client Services held 34,569 shares of CVS Health worth $3.58M as of Q2 2026.
  • Capital Group Private Client Services bought 16,164 CVS Health shares in Q2 2026, an estimated $1.44M.
  • CVS Health made up 0.05% of Capital Group Private Client Services's portfolio in Q2 2026, its #123 holding.
  • Capital Group Private Client Services first reported a position in CVS Health in Q4 2023 and has held it in 10 quarters since.
  • Capital Group Private Client Services's CVS Health position peaked at $28.3M in Q1 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Capital Group Private Client Services's 13F filing for Q2 2026, filed 12 Aug 2026.